Genpact (NYSE:G) Issues FY 2022 Earnings Guidance

Genpact (NYSE:GGet Rating) updated its FY 2022 earnings guidance on Monday. The company provided EPS guidance of $2.60-$2.76 for the period, compared to the consensus EPS estimate of $2.49. The company issued revenue guidance of $4.33 billion-$4.40 billion, compared to the consensus revenue estimate of $4.15 billion.

Several analysts have commented on the stock. Citigroup dropped their target price on shares of Genpact from $62.00 to $55.00 in a research report on Monday, February 14th. Deutsche Bank Aktiengesellschaft dropped their target price on shares of Genpact from $55.00 to $48.00 in a research report on Friday, May 6th. StockNews.com cut shares of Genpact from a strong-buy rating to a buy rating in a research report on Thursday. Cowen lowered shares of Genpact from an outperform rating to a market perform rating and decreased their price target for the company from $57.00 to $51.00 in a report on Monday, February 14th. Finally, Jefferies Financial Group started coverage on shares of Genpact in a report on Wednesday, January 26th. They issued a hold rating and a $54.00 price target for the company. Three research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the company has a consensus rating of Buy and an average target price of $55.71.

Shares of G stock traded down $0.49 on Monday, hitting $42.57. The stock had a trading volume of 11,155 shares, compared to its average volume of 1,062,060. The firm has a market cap of $7.88 billion, a P/E ratio of 22.08, a PEG ratio of 1.50 and a beta of 1.41. The company has a current ratio of 1.43, a quick ratio of 1.47 and a debt-to-equity ratio of 0.68. Genpact has a twelve month low of $37.68 and a twelve month high of $54.03. The company has a fifty day moving average price of $42.31 and a two-hundred day moving average price of $46.81.

Genpact (NYSE:GGet Rating) last issued its quarterly earnings results on Thursday, May 5th. The business services provider reported $0.60 EPS for the quarter, topping the consensus estimate of $0.53 by $0.07. Genpact had a net margin of 9.03% and a return on equity of 24.48%. The firm had revenue of $1.07 billion for the quarter, compared to analysts’ expectations of $1.03 billion. During the same period in the previous year, the firm posted $0.53 EPS. The company’s revenue for the quarter was up 12.9% on a year-over-year basis. On average, analysts expect that Genpact will post 2.34 earnings per share for the current year.

A number of institutional investors have recently added to or reduced their stakes in the business. EverSource Wealth Advisors LLC bought a new position in Genpact in the 4th quarter valued at about $30,000. LPL Financial LLC grew its position in shares of Genpact by 5.5% during the 4th quarter. LPL Financial LLC now owns 10,735 shares of the business services provider’s stock worth $570,000 after purchasing an additional 562 shares in the last quarter. Centaurus Financial Inc. grew its position in shares of Genpact by 14.6% during the 1st quarter. Centaurus Financial Inc. now owns 4,465 shares of the business services provider’s stock worth $194,000 after purchasing an additional 570 shares in the last quarter. Neo Ivy Capital Management acquired a new position in shares of Genpact during the 4th quarter worth approximately $37,000. Finally, Zions Bancorporation N.A. grew its position in shares of Genpact by 9.9% during the 1st quarter. Zions Bancorporation N.A. now owns 8,789 shares of the business services provider’s stock worth $382,000 after purchasing an additional 791 shares in the last quarter. 95.82% of the stock is currently owned by hedge funds and other institutional investors.

About Genpact (Get Rating)

Genpact Limited provides business process outsourcing and information technology (IT) services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Banking, Capital Markets and Insurance; Consumer Goods, Retail, Life Sciences and Healthcare; and High Tech, Manufacturing and Services.

Featured Stories

Receive News & Ratings for Genpact Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genpact and related companies with MarketBeat.com's FREE daily email newsletter.